The role of stent grafts for the maintenance of vascular access in hemodialysis: Analyzing the economic, organizational, and social outcomes
Objective: To assess the multidimensional impact of stent grafts (SG) versus percutaneous transluminal angioplasty (PTA), with or without drug-coated balloons (DCB), for hemodialysis vascular access maintenance. Methods: A multidimensional impact assessment, grounded in the non-clinical domains of Health Technology Assessment, was conducted, focusing on the economic, organizational, social, and environmental sustainability of SG use, from a hospital perspective. A 12-month time-driven activity-based costing approach was used to map real-world clinical pathways for PTA alone, PTA + DCB, and PTA + SG at a teaching hospital in Northern Italy. Administrative data from September 2021 to September 2022 were analyzed, including follow-up for adverse events and re-interventions up to September 2024. Organizational efficiency, patient productivity loss, transportation costs, and CO 2 emissions were quantified to explore social and environmental impacts. Results: At 12 months, SG showed higher initial costs due to device acquisition, but sensitivity analysis indicated a 63% probability that PTA + SG consumes fewer resources than PTA alone, and 51% probability of being less costly than PTA + DCB. Over 24 months, SG reduced the number of re-interventions and adverse events, translating into cost savings of 4% to 19% and up to a 44% saving when excluding device costs. Organizationally, SG reduced outpatient accesses by 53% to 66%, and inpatient days by 37% to 57%. From a social perspective, SG decreased patient productivity loss and transport costs by 61%. Environmentally, SG led to CO 2 emission reductions between 51% and 62%. Conclusions: The selective use of stent grafts within a structured vascular access maintenance strategy may generate substantial economic, organizational, social and environmental benefits. These findings support the role of SG as a complementary component of a stepwise treatment pathway for patients at increased risk of recurrent stenosis and access failure.
Authors
- Marco Franchin (ORCID: https://orcid.org/0000-0002-4193-1923)
- Lucrezia Bianca Ferrario (ORCID: https://orcid.org/0000-0002-8561-898X)
- Matteo Tozzi (ORCID: https://orcid.org/0000-0002-7300-8260)
- Alberto Inguscio
- Emanuela Foglia
Institutions
- University of Insubria (IT)
- University Carlo Cattaneo (IT)
- Aziende Socio Sanitarie Territoriale dei Sette Laghi (IT)
Publication Details
- Journal
- The Journal of Vascular Access
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1177/11297298261500593
- Primary Topic
- Central Venous Catheters and Hemodialysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00